Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 229 to 239 of 239 entries
Sorted by: Best Match Show Resources per page
Commentary on: High-Dose Neuromodulators: A Roundtable on Making Sense of the Data in Real-World Clinical Practice.

Aesthetic surgery journal. Open forum

Shridharani SM.
PMID: 34993470
Aesthet Surg J Open Forum. 2021 Nov 13;3(4):ojab044. doi: 10.1093/asjof/ojab044. eCollection 2021 Dec.

No abstract available.

Cite
Shridharani SM. Commentary on: High-Dose Neuromodulators: A Roundtable on Making Sense of the Data in Real-World Clinical Practice. Aesthet Surg J Open Forum. 2021;3(4):ojab044doi: 10.1093/asjof/ojab044.
Shridharani, S. M. (2021). Commentary on: High-Dose Neuromodulators: A Roundtable on Making Sense of the Data in Real-World Clinical Practice. Aesthetic surgery journal. Open forum, 3(4), ojab044. https://doi.org/10.1093/asjof/ojab044
Shridharani, Sachin M. "Commentary on: High-Dose Neuromodulators: A Roundtable on Making Sense of the Data in Real-World Clinical Practice." Aesthetic surgery journal. Open forum vol. 3,4 (2021): ojab044. doi: https://doi.org/10.1093/asjof/ojab044
Shridharani SM. Commentary on: High-Dose Neuromodulators: A Roundtable on Making Sense of the Data in Real-World Clinical Practice. Aesthet Surg J Open Forum. 2021 Nov 13;3(4):ojab044. doi: 10.1093/asjof/ojab044. eCollection 2021 Dec. PMID: 34993470; PMCID: PMC8728725.
Copy Download .nbib Format: NLM
Mouse Phrenic Nerve Hemidiaphragm Assay (MPN).

Bio-protocol

Zanetti G, Negro S, Pirazzini M, Caccin P.
PMID: 34179283
Bio Protoc. 2018 Mar 05;8(5):e2759. doi: 10.21769/BioProtoc.2759. eCollection 2018 Mar 05.

The neuromuscular junction (NMJ) is the specialized synapse by which peripheral motor neurons innervate muscle fibers and control skeletal muscle contraction. The NMJ is the target of several xenobiotics, including chemicals, plant, animal and bacterial toxins, as well as...

Cite
Zanetti G, Negro S, Pirazzini M, et al. Mouse Phrenic Nerve Hemidiaphragm Assay (MPN). Bio Protoc. 2018;8(5):e2759doi: 10.21769/BioProtoc.2759.
Zanetti, G., Negro, S., Pirazzini, M., & Caccin, P. (2018). Mouse Phrenic Nerve Hemidiaphragm Assay (MPN). Bio-protocol, 8(5), e2759. https://doi.org/10.21769/BioProtoc.2759
Zanetti, Giulia, et al. "Mouse Phrenic Nerve Hemidiaphragm Assay (MPN)." Bio-protocol vol. 8,5 (2018): e2759. doi: https://doi.org/10.21769/BioProtoc.2759
Zanetti G, Negro S, Pirazzini M, Caccin P. Mouse Phrenic Nerve Hemidiaphragm Assay (MPN). Bio Protoc. 2018 Mar 05;8(5):e2759. doi: 10.21769/BioProtoc.2759. eCollection 2018 Mar 05. PMID: 34179283; PMCID: PMC8203881.
Copy Download .nbib Format: NLM
Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes.

PloS one

Saeed-Vafa D, Marchion DC, McCarthy SM, Hakam A, Lopez A, Wenham RM, Apte SM, Chen DT, Magliocco AM, Lancaster JM, Reid BM, Permuth JB.
PMID: 34813586
PLoS One. 2021 Nov 23;16(11):e0256615. doi: 10.1371/journal.pone.0256615. eCollection 2021.

Loss of stromal caveolin-1 (Cav-1) is a biomarker of a cancer-associated fibroblast (CAF) phenotype and is related to progression, metastasis, and poor outcomes in several cancers. The objective of this study was to evaluate the clinical significance of Cav-1...

Cite
Saeed-Vafa D, Marchion DC, McCarthy SM, et al. Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes. PLoS One. 2021;16(11):e0256615doi: 10.1371/journal.pone.0256615.
Saeed-Vafa, D., Marchion, D. C., McCarthy, S. M., Hakam, A., Lopez, A., Wenham, R. M., Apte, S. M., Chen, D. T., Magliocco, A. M., Lancaster, J. M., Reid, B. M., & Permuth, J. B. (2021). Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes. PloS one, 16(11), e0256615. https://doi.org/10.1371/journal.pone.0256615
Saeed-Vafa, Daryoush, et al. "Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes." PloS one vol. 16,11 (2021): e0256615. doi: https://doi.org/10.1371/journal.pone.0256615
Saeed-Vafa D, Marchion DC, McCarthy SM, Hakam A, Lopez A, Wenham RM, Apte SM, Chen DT, Magliocco AM, Lancaster JM, Reid BM, Permuth JB. Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes. PLoS One. 2021 Nov 23;16(11):e0256615. doi: 10.1371/journal.pone.0256615. eCollection 2021. PMID: 34813586; PMCID: PMC8610269.
Copy Download .nbib Format: NLM
Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient.

Case reports in medicine

Patil SS, Patil SM, Campbell R, Singh M, Plotkin M.
PMID: 33224201
Case Rep Med. 2020 Nov 07;2020:6186471. doi: 10.1155/2020/6186471. eCollection 2020.

Medication-induced cutaneous hyperpigmentation has variable clinical presentations and is dependent on the specific drug involved. Most commonly, an attentive patient observes such changes early in the course; when missed by the patient, such changes are usually noted by an...

Cite
Patil SS, Patil SM, Campbell R, et al. Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient. Case Rep Med. 2020;2020:6186471doi: 10.1155/2020/6186471.
Patil, S. S., Patil, S. M., Campbell, R., Singh, M., & Plotkin, M. (2020). Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient. Case reports in medicine, 20206186471. https://doi.org/10.1155/2020/6186471
Patil, Shakuntala S, et al. "Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient." Case reports in medicine vol. 2020 (2020): 6186471. doi: https://doi.org/10.1155/2020/6186471
Patil SS, Patil SM, Campbell R, Singh M, Plotkin M. Levofloxacin-Induced Acute Hyperpigmentation Changes in a Chronic Kidney Disease Patient. Case Rep Med. 2020 Nov 07;2020:6186471. doi: 10.1155/2020/6186471. eCollection 2020. PMID: 33224201; PMCID: PMC7669357.
Copy Download .nbib Format: NLM
A recessive PRDM13 mutation results in congenital hypogonadotropic hypogonadism and cerebellar hypoplasia.

The Journal of clinical investigation

Whittaker DE, Oleari R, Gregory LC, Le Quesne-Stabej P, Williams HJ, Torpiano JG, Formosa N, Cachia MJ, Field D, Lettieri A, Ocaka LA, Paganoni AJ, Rajabali SH, Riegman KL, De Martini LB, Chaya T, Robinson IC, Furukawa T, Cariboni A, Basson MA, Dattani MT.
PMID: 34730112
J Clin Invest. 2021 Dec 15;131(24). doi: 10.1172/JCI141587.

The positive regulatory (PR) domain containing 13 (PRDM13) putative chromatin modifier and transcriptional regulator functions downstream of the transcription factor PTF1A, which controls GABAergic fate in the spinal cord and neurogenesis in the hypothalamus. Here, we report a recessive...

Cite
Whittaker DE, Oleari R, Gregory LC, et al. A recessive PRDM13 mutation results in congenital hypogonadotropic hypogonadism and cerebellar hypoplasia. J Clin Invest. 2021;131(24)doi: 10.1172/JCI141587.
Whittaker, D. E., Oleari, R., Gregory, L. C., Le Quesne-Stabej, P., Williams, H. J., Torpiano, J. G., Formosa, N., Cachia, M. J., Field, D., Lettieri, A., Ocaka, L. A., Paganoni, A. J., Rajabali, S. H., Riegman, K. L., De Martini, L. B., Chaya, T., Robinson, I. C., Furukawa, T., Cariboni, A., Basson, M. A., & Dattani, M. T. (2021). A recessive PRDM13 mutation results in congenital hypogonadotropic hypogonadism and cerebellar hypoplasia. The Journal of clinical investigation, 131(24), . https://doi.org/10.1172/JCI141587
Whittaker, Danielle E, et al. "A recessive PRDM13 mutation results in congenital hypogonadotropic hypogonadism and cerebellar hypoplasia." The Journal of clinical investigation vol. 131,24 (2021). doi: https://doi.org/10.1172/JCI141587
Whittaker DE, Oleari R, Gregory LC, Le Quesne-Stabej P, Williams HJ, Torpiano JG, Formosa N, Cachia MJ, Field D, Lettieri A, Ocaka LA, Paganoni AJ, Rajabali SH, Riegman KL, De Martini LB, Chaya T, Robinson IC, Furukawa T, Cariboni A, Basson MA, Dattani MT. A recessive PRDM13 mutation results in congenital hypogonadotropic hypogonadism and cerebellar hypoplasia. J Clin Invest. 2021 Dec 15;131(24). doi: 10.1172/JCI141587. PMID: 34730112; PMCID: PMC8670848.
Copy Download .nbib Format: NLM
Developing a Theory-Informed Smartphone App for Early Psychosis: Learning Points From a Multidisciplinary Collaboration.

Frontiers in psychiatry

Berry N, Machin M, Ainsworth J, Berry K, Edge D, Haddock G, Lewis S, Morris R, Bucci S.
PMID: 33362612
Front Psychiatry. 2020 Dec 10;11:602861. doi: 10.3389/fpsyt.2020.602861. eCollection 2020.

No abstract available.

Cite
Berry N, Machin M, Ainsworth J, et al. Developing a Theory-Informed Smartphone App for Early Psychosis: Learning Points From a Multidisciplinary Collaboration. Front Psychiatry. 2020;11:602861doi: 10.3389/fpsyt.2020.602861.
Berry, N., Machin, M., Ainsworth, J., Berry, K., Edge, D., Haddock, G., Lewis, S., Morris, R., & Bucci, S. (2020). Developing a Theory-Informed Smartphone App for Early Psychosis: Learning Points From a Multidisciplinary Collaboration. Frontiers in psychiatry, 11602861. https://doi.org/10.3389/fpsyt.2020.602861
Berry, Natalie, et al. "Developing a Theory-Informed Smartphone App for Early Psychosis: Learning Points From a Multidisciplinary Collaboration." Frontiers in psychiatry vol. 11 (2020): 602861. doi: https://doi.org/10.3389/fpsyt.2020.602861
Berry N, Machin M, Ainsworth J, Berry K, Edge D, Haddock G, Lewis S, Morris R, Bucci S. Developing a Theory-Informed Smartphone App for Early Psychosis: Learning Points From a Multidisciplinary Collaboration. Front Psychiatry. 2020 Dec 10;11:602861. doi: 10.3389/fpsyt.2020.602861. eCollection 2020. PMID: 33362612; PMCID: PMC7758439.
Copy Download .nbib Format: NLM
Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model.

Antiviral research

Cochin M, Touret F, Driouich JS, Moureau G, Petit PR, Laprie C, Solas C, de Lamballerie X, Nougairède A.
PMID: 34838583
Antiviral Res. 2021 Nov 24;197:105212. doi: 10.1016/j.antiviral.2021.105212. Epub 2021 Nov 24.

Drug repositioning has been used extensively since the beginning of the COVID-19 pandemic in an attempt to identify antiviral molecules for use in human therapeutics. Hydroxychloroquine and azithromycin have shown inhibitory activity against SARS-CoV-2 replication in different cell lines....

Cite
Cochin M, Touret F, Driouich JS, et al. Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model. Antiviral Res. 2021;197:105212doi: 10.1016/j.antiviral.2021.105212.
Cochin, M., Touret, F., Driouich, J. S., Moureau, G., Petit, P. R., Laprie, C., Solas, C., de Lamballerie, X., & Nougairède, A. (2021). Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model. Antiviral research, 197105212. https://doi.org/10.1016/j.antiviral.2021.105212
Cochin, Maxime, et al. "Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model." Antiviral research vol. 197 (2021): 105212. doi: https://doi.org/10.1016/j.antiviral.2021.105212
Cochin M, Touret F, Driouich JS, Moureau G, Petit PR, Laprie C, Solas C, de Lamballerie X, Nougairède A. Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model. Antiviral Res. 2021 Nov 24;197:105212. doi: 10.1016/j.antiviral.2021.105212. Epub 2021 Nov 24. PMID: 34838583; PMCID: PMC8611861.
Copy Download .nbib Format: NLM
Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model.

Antiviral research

Cochin M, Touret F, Driouich JS, Moureau G, Petit PR, Laprie C, Solas C, de Lamballerie X, Nougairède A.
PMID: 34838583
Antiviral Res. 2021 Nov 24;197:105212. doi: 10.1016/j.antiviral.2021.105212. Epub 2021 Nov 24.

Drug repositioning has been used extensively since the beginning of the COVID-19 pandemic in an attempt to identify antiviral molecules for use in human therapeutics. Hydroxychloroquine and azithromycin have shown inhibitory activity against SARS-CoV-2 replication in different cell lines....

Cite
Cochin M, Touret F, Driouich JS, et al. Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model. Antiviral Res. 2021;197:105212doi: 10.1016/j.antiviral.2021.105212.
Cochin, M., Touret, F., Driouich, J. S., Moureau, G., Petit, P. R., Laprie, C., Solas, C., de Lamballerie, X., & Nougairède, A. (2021). Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model. Antiviral research, 197105212. https://doi.org/10.1016/j.antiviral.2021.105212
Cochin, Maxime, et al. "Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model." Antiviral research vol. 197 (2021): 105212. doi: https://doi.org/10.1016/j.antiviral.2021.105212
Cochin M, Touret F, Driouich JS, Moureau G, Petit PR, Laprie C, Solas C, de Lamballerie X, Nougairède A. Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model. Antiviral Res. 2021 Nov 24;197:105212. doi: 10.1016/j.antiviral.2021.105212. Epub 2021 Nov 24. PMID: 34838583; PMCID: PMC8611861.
Copy Download .nbib Format: NLM
Evaluating a Topical Adjunctive Post Submental ATX-101 (Deoxycholic Acid) Injections for Improved Recovery: A Single-Center, Double-Blind, Randomized Controlled Pilot Study.

Aesthetic surgery journal. Open forum

Shridharani SM.
PMID: 34386769
Aesthet Surg J Open Forum. 2021 Jun 29;3(3):ojab028. doi: 10.1093/asjof/ojab028. eCollection 2021 Sep.

No abstract available.

Cite
Shridharani SM. Evaluating a Topical Adjunctive Post Submental ATX-101 (Deoxycholic Acid) Injections for Improved Recovery: A Single-Center, Double-Blind, Randomized Controlled Pilot Study. Aesthet Surg J Open Forum. 2021;3(3):ojab028doi: 10.1093/asjof/ojab028.
Shridharani, S. M. (2021). Evaluating a Topical Adjunctive Post Submental ATX-101 (Deoxycholic Acid) Injections for Improved Recovery: A Single-Center, Double-Blind, Randomized Controlled Pilot Study. Aesthetic surgery journal. Open forum, 3(3), ojab028. https://doi.org/10.1093/asjof/ojab028
Shridharani, Sachin M. "Evaluating a Topical Adjunctive Post Submental ATX-101 (Deoxycholic Acid) Injections for Improved Recovery: A Single-Center, Double-Blind, Randomized Controlled Pilot Study." Aesthetic surgery journal. Open forum vol. 3,3 (2021): ojab028. doi: https://doi.org/10.1093/asjof/ojab028
Shridharani SM. Evaluating a Topical Adjunctive Post Submental ATX-101 (Deoxycholic Acid) Injections for Improved Recovery: A Single-Center, Double-Blind, Randomized Controlled Pilot Study. Aesthet Surg J Open Forum. 2021 Jun 29;3(3):ojab028. doi: 10.1093/asjof/ojab028. eCollection 2021 Sep. PMID: 34386769; PMCID: PMC8353883.
Copy Download .nbib Format: NLM
Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model.

Antiviral research

Cochin M, Touret F, Driouich JS, Moureau G, Petit PR, Laprie C, Solas C, de Lamballerie X, Nougairède A.
PMID: 34838583
Antiviral Res. 2022 Jan;197:105212. doi: 10.1016/j.antiviral.2021.105212. Epub 2021 Nov 24.

Drug repositioning has been used extensively since the beginning of the COVID-19 pandemic in an attempt to identify antiviral molecules for use in human therapeutics. Hydroxychloroquine and azithromycin have shown inhibitory activity against SARS-CoV-2 replication in different cell lines....

Cite
Cochin M, Touret F, Driouich JS, et al. Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model. Antiviral Res. 2021;197:105212doi: 10.1016/j.antiviral.2021.105212.
Cochin, M., Touret, F., Driouich, J. S., Moureau, G., Petit, P. R., Laprie, C., Solas, C., de Lamballerie, X., & Nougairède, A. (2022). Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model. Antiviral research, 197105212. https://doi.org/10.1016/j.antiviral.2021.105212
Cochin, Maxime, et al. "Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model." Antiviral research vol. 197 (2022): 105212. doi: https://doi.org/10.1016/j.antiviral.2021.105212
Cochin M, Touret F, Driouich JS, Moureau G, Petit PR, Laprie C, Solas C, de Lamballerie X, Nougairède A. Hydroxychloroquine and azithromycin used alone or combined are not effective against SARS-CoV-2 ex vivo and in a hamster model. Antiviral Res. 2022 Jan;197:105212. doi: 10.1016/j.antiviral.2021.105212. Epub 2021 Nov 24. PMID: 34838583; PMCID: PMC8611861.
Copy Download .nbib Format: NLM
Computerized Tomography-Guided Core-Needle Biopsy of Orbital Space-Occupying Lesions: A Case Series.

Ocular oncology and pathology

Bata BM, Martin A, Connolly D, Mudhar HS, Hersey N, Salvi SM.
PMID: 33796518
Ocul Oncol Pathol. 2021 Mar;7(1):54-61. doi: 10.1159/000510867. Epub 2020 Nov 30.

PURPOSE: To describe our experience in performing biopsy of post-septal orbital masses with core needle under computerized tomography guidance (CT-CNB).METHODS: The medical records of all patients who underwent this procedure were reviewed. The procedure was performed under local anesthesia...

Cite
Bata BM, Martin A, Connolly D, et al. Computerized Tomography-Guided Core-Needle Biopsy of Orbital Space-Occupying Lesions: A Case Series. Ocul Oncol Pathol. 2020;7(1):54-61doi: 10.1159/000510867.
Bata, B. M., Martin, A., Connolly, D., Mudhar, H. S., Hersey, N., & Salvi, S. M. (2021). Computerized Tomography-Guided Core-Needle Biopsy of Orbital Space-Occupying Lesions: A Case Series. Ocular oncology and pathology, 7(1), 54-61. https://doi.org/10.1159/000510867
Bata, Bashar M, et al. "Computerized Tomography-Guided Core-Needle Biopsy of Orbital Space-Occupying Lesions: A Case Series." Ocular oncology and pathology vol. 7,1 (2021): 54-61. doi: https://doi.org/10.1159/000510867
Bata BM, Martin A, Connolly D, Mudhar HS, Hersey N, Salvi SM. Computerized Tomography-Guided Core-Needle Biopsy of Orbital Space-Occupying Lesions: A Case Series. Ocul Oncol Pathol. 2021 Mar;7(1):54-61. doi: 10.1159/000510867. Epub 2020 Nov 30. PMID: 33796518; PMCID: PMC7989668.
Copy Download .nbib Format: NLM
Showing 229 to 239 of 239 entries